How Has the Latex Agglutination Test Kits Market Evolved Historically and What is its Current Size?
The latex agglutination test kits market has seen considerable growth due to a variety of factors.
• The latex agglutination test kits market has experienced strong growth in recent years, expected to grow from $1.49 billion in 2024 to $1.6 billion in 2025, at a CAGR of 7.4%.
This growth is driven by the increasing prevalence of infectious diseases, rising research and development funding in diagnostics, a greater focus on infection control in healthcare facilities, and the growing adoption of these tests in water quality testing.
What is the Forecasted Market Size and CAGR for the Latex Agglutination Test Kits Market?
The latex agglutination test kits market is expected to maintain its strong growth trajectory in upcoming years.
• The latex agglutination test kits market is projected to grow to $2.09 billion by 2029, with a compound annual growth rate (CAGR) of 7.0%.
This growth is driven by the increasing prevalence of infectious and autoimmune diseases, the rising adoption of rapid and point-of-care (POC) technology, greater awareness about sexually transmitted infections, and a rise in respiratory tract infections. Key trends include technological advancements, test strip technology, antigen tests, automated technologies, and point-of-care testing.
What Key Factors and Trends Are Driving The Growth Latex Agglutination Test Kits Market?
The rising prevalence of infectious diseases is expected to drive the latex agglutination test kit market. Infectious diseases are increasing due to factors like globalization and antimicrobial resistance, with latex agglutination tests helping detect these diseases. For example, in March 2023, the CDC reported 8,331 cases of tuberculosis in the U.S. in 2022, a 5.9% increase from the previous year, highlighting the demand for such test kits.
What Are The Market Segments In The Latex Agglutination Test Kits Market?
The latex agglutination test kits market covered in this report is segmented –
1) By Product Type: Enzyme Linked Immunosorbent Assay, Indirect Fluorescent, Hemagglutination Inhibition, Serum Neutralization
2) By Test Type: Antibody Detection, Antigen Testing
3) By Sample Type: Blood, Urine, Cerebrospinal Fluid, Other Sample Types
4) By Application: Hospitals, Diagnostic Centers, Specialty Clinics
Subsegments:
1) By Enzyme-Linked Immunosorbent Assay (Elisa): Sandwich Elisa, Competitive Elisa, Indirect Elisa
2) By Indirect Fluorescent: Direct Immunofluorescence Assay (Difa), Indirect Immunofluorescence Assay (Ifa)
3) By Hemagglutination Inhibition: Virus-Specific Hemagglutination Inhibition Tests
4) By Serum Neutralization: Virus Neutralization Assays, Cytopathic Effect Neutralization Assays
Pre-Book The Latex Agglutination Test Kits Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Latex Agglutination Test Kits Market?
Leading companies in the latex agglutination test kits market are channeling their resources towards the development of diagnostic tools for detecting foodborne diseases and environmental pollutants. These include quick and easy-to-use latex agglutination examinations, aimed at improving illness detection and gaining market advantage. These user-friendly assays simplify the process of pathogen identification, allowing for quick and accurate detection in food and environmental specimens. For example, in March 2024, Gold Standard Diagnostics LLC, a diagnostic firm based in the US, introduced Microgen rapid latex agglutination tests. These tests are a series of swift, simple, and cost-effective methods, established by Gold Standard Diagnostics, for definitive confirmation of specific pathogens in food and environmental specimens, including Salmonella, Legionella, or Staphylococcus aureus colonies. As an alternative to traditional culture methods, these tests offer high sensitivity and specificity, and can be completed in just two minutes. They can be seamlessly incorporated into lab routines. These tests are so easy to use that labs can implement them immediately without requiring special training or equipment.
Who Are the Key Players In The Latex Agglutination Test Kits Market?
Major companies operating in the latex agglutination test kits market are:
• Cardinal Health Inc.
• Thermo Fisher Scientific Inc.
• Becton Dickinson and Company
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• Hardy Diagnostics
• Meridian Bioscience Inc.
• BioLegend Inc.
• ELITechGroup
• Fujirebio
• Sekisui Diagnostics LLC
• R-Biopharm AG
• Savyon Diagnostics Ltd.
• Creative Diagnostics
• ZeptoMetrix Corporation
• HiMedia Laboratories
• DIALAB GmbH
• Arlington Scientific Inc.
• Biotium Inc.
• Atlas Medical GmbH
• Pro Lab Diagnostics Inc.
• Gold Standard Diagnostics Industrial Solutions
What Are The Regional Insights Into The Latex Agglutination Test Kits Market?
North America was the largest region in the latex agglutination test kits market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the latex agglutination test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
